Immunoprecise Antibodies (CVE:IPA) Reaches New 52-Week Low at $0.56
Shares of Immunoprecise Antibodies Ltd (CVE:IPA) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.56 and last traded at C$0.57, with a volume of 16500 shares trading hands. The stock had previously closed at C$0.58.
The company has a debt-to-equity ratio of 14.37, a current ratio of 3.67 and a quick ratio of 3.32. The business’s 50 day simple moving average is C$0.68. The firm has a market cap of $38.98 million and a PE ratio of -5.49.
Immunoprecise Antibodies Company Profile (CVE:IPA)
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services.
Read More: What is the definition of a trade war?
Receive News & Ratings for Immunoprecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunoprecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.